News + Filings Transactions Holdings
All
13F
13D/G
Other
|
|
New Enterprise Associates 12, Limited Partnership
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 01/05/2022 |
SC 13D/A
| New Enterprise Associates 12, Limited Partnership has filed a Schedule 13D for Liquidia Corporation |
| 12/29/2021 |
SC 13D/A
| New Enterprise Associates 12, Limited Partnership has filed a Schedule 13D for Ardelyx, Inc. |
| 03/10/2021 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 03/10/2021 |
SC 13D/A
| New Enterprise Associates 12, Limited Partnership has filed a Schedule 13D for Trevena, Inc. |
| 07/07/2020 |
SC 13D/A
| New Enterprise Associates 12, Limited Partnership reports a 6.7% stake in Liquidia Technologies, Inc. |
| 06/18/2020 |
SC 13D/A
| New Enterprise Associates 12, Limited Partnership reports a 15.3% stake in Ardelyx, Inc. |
| 06/12/2020 |
4
| New Enterprise Associates 12, Limited Partnership (10% Owner) has filed a Form 4 on ARDELYX, INC.|
Txns:
| Disposed of 1,482,809 shares
@ $0 |
|
| 12/09/2019 |
4
| New Enterprise Associates 12, Limited Partnership (10% Owner) has filed a Form 4 on ARDELYX, INC.|
Txns:
| Granted 400,000 shares
@ $6.25, valued at
$2.5M
|
|
| 12/06/2019 |
SC 13D/A
| New Enterprise Associates 12, Limited Partnership has filed a Schedule 13D for Proteostasis Therapeutics, Inc. |
| 11/29/2019 |
4
| New Enterprise Associates 12, Limited Partnership (10% Owner) has filed a Form 4 on PROTEOSTASIS THERAPEUTICS, INC.|
Txns:
| Sold 117,164 shares
@ $2.4507, valued at
$287.1k
Sold 1,166,755 shares
@ $2.5213, valued at
$2.9M
|
|
| 08/06/2018 |
SC 13D
| New Enterprise Associates 12, Limited Partnership reports a 16.7% stake in Liquidia Technologies, Inc. |
| 08/01/2018 |
4
| New Enterprise Associates 12, Limited Partnership (10% Owner) has filed a Form 4 on Liquidia Technologies Inc|
Txns:
| Converted 515,547 shares
@ $0
Converted 432,033 shares
@ $0
Converted 980,715 shares
@ $0
Bought 545,455 shares
@ $11, valued at
$6M
Converted 3,645,307 preferred shares
@ $0
Converted 3,337,206 preferred shares
@ $0
Converted 16,502,833 preferred shares
@ $0
Disposed of 684,911 options to buy
@ $0.01, valued at
$6.8k
Acquired 40,702 options to buy
@ $0.01, valued at
$407 |
|
| 07/25/2018 |
3
| New Enterprise Associates 12, Limited Partnership (10% Owner) has filed a Form 3 on Liquidia Technologies Inc |
| 06/05/2018 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 05/30/2018 |
4
| New Enterprise Associates 12, Limited Partnership (10% Owner) has filed a Form 4 on ARDELYX, INC.|
Txns:
| Granted 416,667 shares
@ $4, valued at
$1.7M
|
|
| 03/06/2018 |
SC 13D/A
| New Enterprise Associates 12, Limited Partnership reports a 19.3% stake in Tintri, Inc. |
| 03/02/2018 |
4
| New Enterprise Associates 12, Limited Partnership (10% Owner) has filed a Form 4 on Tintri, Inc.|
Txns:
| Unknown transaction of options to buy
@ $7, valued at
$0 |
|
| 01/10/2018 |
SC 13G/A
| New Enterprise Associates 12, Limited Partnership has filed a Schedule 13D for Zosano Pharma Corporation |
| 12/21/2017 |
SC 13D/A
| New Enterprise Associates 12, Limited Partnership reports a 17% stake in Proteostasis Therapeutics, Inc. |
| 12/19/2017 |
4
| New Enterprise Associates 12, Limited Partnership (10% Owner) has filed a Form 4 on PROTEOSTASIS THERAPEUTICS, INC.|
Txns:
| Bought 2,000,000 shares
@ $5, valued at
$10M
|
|
| 08/11/2017 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 07/13/2017 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership: |
| 07/10/2017 |
4
| New Enterprise Associates 12, Limited Partnership (10% Owner) has filed a Form 4 on Tintri, Inc.|
Txns:
| Converted 1,261,666 shares
@ $0
Converted 773,429 shares
@ $0
Converted 689,700 shares
@ $0
Converted 314,562 shares
@ $0
Converted 709,638 shares
@ $0
Converted 572,935 shares
@ $0
Bought 926,429 shares
@ $7, valued at
$6.5M
Converted 1,261,666 preferred shares
@ $0
Converted 773,429 preferred shares
@ $0
Converted 689,700 preferred shares
@ $0
Converted 314,562 preferred shares
@ $0 |
|
| 06/29/2017 |
3
| New Enterprise Associates 12, Limited Partnership (10% Owner) has filed a Form 3 on Tintri, Inc. |
| 02/14/2017 |
4
| New Enterprise Associates 12, Limited Partnership (10% Owner) has filed a Form 4 on Zosano Pharma Corp|
Txns:
| Sold 1,099,996 shares
@ $2.0104, valued at
$2.2M
|
|
| 02/13/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 09/20/2016 |
4
| New Enterprise Associates 12, Limited Partnership (10% Owner) has filed a Form 4 on Zosano Pharma Corp |
| 09/20/2016 |
SC 13D/A
| PROTEOSTASIS THERAPEUTICS, INC. reports a 14.8% stake in Proteostasis Therapeutics, Inc. |
| 08/26/2016 |
4
| New Enterprise Associates 12, Limited Partnership (10% Owner) has filed a Form 4 on Zosano Pharma Corp |
| 08/12/2016 |
SC 13D/A
| Groupon, Inc. reports a 3.8% stake in Groupon, Inc. |
| 07/28/2016 |
SC 13D/A
| ARDELYX, INC. reports a 43% stake in Ardelyx, Inc. |
| 07/20/2016 |
4
| New Enterprise Associates 12, Limited Partnership (10% Owner) has filed a Form 4 on ARDELYX, INC. |
| 07/15/2016 |
4
| New Enterprise Associates 12, Limited Partnership (10% Owner) has filed a Form 4 on Zosano Pharma Corp |
| 06/16/2016 |
SC 13G/A
| OPOWER, INC. has filed a Schedule 13D for Opower, Inc. |
|
|
|